Nelarabine 5 mg/mL Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 5 mg/mL
Reference Brands: Arranon (USA)
Category: Oncology Cancer Care
Nelarabine is a Oncology Cancer Care product available as Injection in strengths 5 mg/mL. It corresponds to the reference brand Arranon (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.
Product Description:
Nelarabine injection is an antineoplastic medication used in the treatment of specific types of cancer, including T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL). It is generally prescribed for patients whose disease has not responded to, or has relapsed after, treatment with at least two other cancer therapies. Nelarabine is administered by intravenous injection under strict medical supervision, usually in specialized oncology settings.
Nelarabine belongs to a group of medicines known as antineoplastics and works by interfering with the growth and replication of cancer cells. By disrupting cellular processes essential for cancer cell survival, nelarabine leads to the destruction of malignant T-cells. However, because this medicine can also affect normal, rapidly dividing cells in the body, patients may experience side effects during treatment.
Nelarabine — third party manufacturing & bulk supply
Nelarabine 5 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Nelarabine is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Nelarabine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Nelarabine →Frequently Asked Questions
Nelarabine is used to treat T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) in patients who have not responded to or have relapsed after at least two prior chemotherapy regimens.
Nelarabine is a synthetically produced nucleoside analog antineoplastic agent.
The trade name of nelarabine is Arranon.
Arranon was originally developed and marketed by GlaxoSmithKline (GSK).
The generic name of Nelarabine is nelarabine.
The brand name of Nelarabine is Arranon.
Nelarabine is manufactured in multiple countries including the United States and EU nations, depending on the manufacturer and regulatory approvals.
Related Products
Nilutamide
Strength:
150 mg
Form: Tablets
Reference Brands: Nilandron (USA), Nilandron (EU)
View DetailsGemtuzumab Ozogamicin
Strength:
4.5 mg
Form: Injection
Reference Brands: Mylotarg (USA)
View DetailsImetelstat
Strength:
47 mg, 188 mg
Form: Injection
Reference Brands: Generic formulations marketed under different names
View DetailsRegorafenib
Strength:
40 mg, 80 mg, 120 mg, 160 mg
Form: Tablets
Reference Brands: Stivarga (USA/EU)
View DetailsHistrelin Acetate
Strength:
50 mg
Form: Subcutaneous implant
Reference Brands: Vantas (USA), Supprelin LA (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers